Legend Biotech CFO to resign
Dec 23 (Reuters) - Cancer therapy maker Legend Biotech's Chief Financial Officer Lori Macomber has submitted her resignation notice to the company, a filing with the U.S. Securities and Exchange Commission showed on Monday.
Macomber, who was promoted to the CFO role in 2022, would step down due to personal reasons, effective Jan. 2, 2025, the filing added.
Insider Jessie Yeung has been appointed as the interim CFO and the board has designated her as company's interim principal financial officer.
(Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Mohammed Safi Shamsi)
